Prednisolone: role in amoxicillin-clavulanate-induced cholestatic liver injury

BMJ Case Rep. 2021 Apr 1;14(4):e239488. doi: 10.1136/bcr-2020-239488.

Abstract

A 68-year-old patient presented with symptoms of a urinary tract infection. A deterioration in the patient's liver function tests (LFTs) was noted 1 week following completion of a course of amoxicillin-clavunalate. This progressively worsened, reaching its peak by day 30. Our investigations excluded other possible causes for deranged LFTs and there was no improvement of same despite reduced dosing of potentially hepatotoxic medications.A trial of 30 mg/day prednisolone was commenced, resulting in an immediate and progressive improvement in LFTs to baseline over a period of 22 days and an improvement in constitutional symptoms such as tiredness and poor appetite. Drug-induced liver injury (DILI) is one of the common causes of acute hepatitis and a leading cause of acute liver failure in the US and Europe. Patterns of DILI can be generally divided into: (1) hepatocellular injury, (2) cholestatic injury and (3) mixed injury.

Keywords: drugs and medicines; liver disease; unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amoxicillin / adverse effects
  • Amoxicillin-Potassium Clavulanate Combination / adverse effects
  • Chemical and Drug Induced Liver Injury* / etiology
  • Europe
  • Humans
  • Liver
  • Prednisolone* / therapeutic use

Substances

  • Amoxicillin-Potassium Clavulanate Combination
  • Amoxicillin
  • Prednisolone